EP 2081563 A1 20090729 - PHARMACEUTICAL FORMULATIONS
Title (en)
PHARMACEUTICAL FORMULATIONS
Title (de)
PHARMAZEUTISCHE FORMULIERUNGEN
Title (fr)
FORMULATIONS PHARMACEUTIQUES
Publication
Application
Priority
- US 2007081267 W 20071012
- US 82925506 P 20061012
Abstract (en)
[origin: WO2008046052A1] The present invention provides a modified release formulation comprising an active agent in a hydrophilic polymer matrix wherein the active agent is a salt of fenofibric acid wherein the release rate of the formulation in an in vitro dissolution is substantially independent of the ionic strength of the dissolution media.
IPC 8 full level
A61K 31/192 (2006.01); A61K 9/16 (2006.01); A61K 9/20 (2006.01); A61K 9/28 (2006.01)
CPC (source: EP KR)
A61K 9/1623 (2013.01 - EP KR); A61K 9/1652 (2013.01 - EP KR); A61K 9/2018 (2013.01 - EP KR); A61K 9/2054 (2013.01 - EP KR); A61K 9/2846 (2013.01 - EP KR); A61K 31/192 (2013.01 - EP KR); A61K 47/38 (2013.01 - KR); A61P 3/06 (2018.01 - EP KR)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK RS
DOCDB simple family (publication)
WO 2008046052 A1 20080417; AU 2007307641 A1 20080417; CA 2672686 A1 20080417; CN 101677981 A 20100324; CO 6160302 A2 20100520; EA 200900531 A1 20091230; EC SP099251 A 20090630; EP 2081563 A1 20090729; IL 198160 A0 20091224; JP 2010506855 A 20100304; KR 20090119959 A 20091123; MX 2009003815 A 20090907; SG 175570 A1 20111128; ZA 200902488 B 20101027
DOCDB simple family (application)
US 2007081267 W 20071012; AU 2007307641 A 20071012; CA 2672686 A 20071012; CN 200780045748 A 20071012; CO 09036680 A 20090413; EA 200900531 A 20071012; EC SP099251 A 20090413; EP 07844238 A 20071012; IL 19816009 A 20090416; JP 2009532610 A 20071012; KR 20097007466 A 20071012; MX 2009003815 A 20071012; SG 2011070588 A 20071012; ZA 200902488 A 20071012